nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—conduct disorder	0.975	1	CbGaD
Cyamemazine—HTR2C—Serotonin receptors—HTR2A—conduct disorder	0.00135	0.0822	CbGpPWpGaD
Cyamemazine—HTR2C—Monoamine GPCRs—DRD4—conduct disorder	0.000924	0.0561	CbGpPWpGaD
Cyamemazine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—conduct disorder	0.0009	0.0546	CbGpPWpGaD
Cyamemazine—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.000803	0.0487	CbGpPWpGaD
Cyamemazine—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.000788	0.0478	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.000777	0.0472	CbGpPWpGaD
Cyamemazine—Propiomazine—DRD4—conduct disorder	0.000692	0.0827	CrCbGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.000675	0.041	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.000662	0.0402	CbGpPWpGaD
Cyamemazine—HTR2C—Monoamine GPCRs—HTR2A—conduct disorder	0.000603	0.0366	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—DRD4—conduct disorder	0.000592	0.0707	CrCbGaD
Cyamemazine—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.000514	0.0312	CbGpPWpGaD
Cyamemazine—Promazine—DRD4—conduct disorder	0.000513	0.0613	CrCbGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000507	0.0308	CbGpPWpGaD
Cyamemazine—Chlorpromazine—DRD4—conduct disorder	0.000451	0.0539	CrCbGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000432	0.0262	CbGpPWpGaD
Cyamemazine—Acepromazine—HTR2A—conduct disorder	0.000399	0.0477	CrCbGaD
Cyamemazine—Clomipramine—SLC6A4—conduct disorder	0.000395	0.0472	CrCbGaD
Cyamemazine—Thioproperazine—HTR2A—conduct disorder	0.00039	0.0466	CrCbGaD
Cyamemazine—Pipotiazine—HTR2A—conduct disorder	0.000384	0.0459	CrCbGaD
Cyamemazine—Mesoridazine—HTR2A—conduct disorder	0.000379	0.0453	CrCbGaD
Cyamemazine—Trimipramine—SLC6A4—conduct disorder	0.000363	0.0434	CrCbGaD
Cyamemazine—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000357	0.0216	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.00035	0.0213	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000338	0.0205	CbGpPWpGaD
Cyamemazine—Fluphenazine—HTR2A—conduct disorder	0.000332	0.0396	CrCbGaD
Cyamemazine—Propiomazine—HTR2A—conduct disorder	0.000319	0.0381	CrCbGaD
Cyamemazine—Clomipramine—HTR2A—conduct disorder	0.000303	0.0363	CrCbGaD
Cyamemazine—Chlorprothixene—HTR2A—conduct disorder	0.000302	0.0361	CrCbGaD
Cyamemazine—Thioridazine—HTR2A—conduct disorder	0.000286	0.0342	CrCbGaD
Cyamemazine—Trimipramine—HTR2A—conduct disorder	0.000279	0.0334	CrCbGaD
Cyamemazine—Methotrimeprazine—HTR2A—conduct disorder	0.000273	0.0326	CrCbGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000273	0.0166	CbGpPWpGaD
Cyamemazine—Imipramine—SLC6A4—conduct disorder	0.000269	0.0322	CrCbGaD
Cyamemazine—Promethazine—HTR2A—conduct disorder	0.000269	0.0321	CrCbGaD
Cyamemazine—Trifluoperazine—HTR2A—conduct disorder	0.000265	0.0317	CrCbGaD
Cyamemazine—Perphenazine—HTR2A—conduct disorder	0.000262	0.0313	CrCbGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000246	0.015	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000242	0.0147	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000237	0.0144	CbGpPWpGaD
Cyamemazine—Promazine—HTR2A—conduct disorder	0.000237	0.0283	CrCbGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000233	0.0141	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.000228	0.0139	CbGpPWpGaD
Cyamemazine—Chlorpromazine—HTR2A—conduct disorder	0.000208	0.0249	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—CGA—conduct disorder	0.000208	0.0126	CbGpPWpGaD
Cyamemazine—Imipramine—HTR2A—conduct disorder	0.000207	0.0247	CrCbGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000185	0.0113	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000182	0.0111	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.00018	0.011	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000178	0.0108	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.000177	0.0108	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.000164	0.00995	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000155	0.0094	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000153	0.00928	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000152	0.00923	CbGpPWpGaD
Cyamemazine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000151	0.00914	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000148	0.00901	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000135	0.00817	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000133	0.00806	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00013	0.00791	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000117	0.00713	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000116	0.00706	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000116	0.00706	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000107	0.00647	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000102	0.00619	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000101	0.00613	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.0001	0.00608	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.97e-05	0.00605	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.92e-05	0.00602	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	9.92e-05	0.00602	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	9.26e-05	0.00562	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CGA—conduct disorder	9.09e-05	0.00552	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.5e-05	0.00516	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.01e-05	0.00486	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	7.86e-05	0.00477	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	7.59e-05	0.00461	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	6.58e-05	0.00399	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	6.47e-05	0.00393	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CGA—conduct disorder	6.3e-05	0.00382	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.97e-05	0.00363	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.71e-05	0.00347	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	5.61e-05	0.0034	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CGA—conduct disorder	5.47e-05	0.00332	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CGA—conduct disorder	5.37e-05	0.00326	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	5.19e-05	0.00315	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	5.09e-05	0.00309	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—WASF1—conduct disorder	5.05e-05	0.00306	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	4.38e-05	0.00266	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—WASF1—conduct disorder	4.3e-05	0.00261	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	4.29e-05	0.0026	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.9e-05	0.00237	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	3.66e-05	0.00222	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.53e-05	0.00214	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	3.32e-05	0.00202	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	3.06e-05	0.00186	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD4—conduct disorder	3.01e-05	0.00183	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.3e-05	0.0014	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.96e-05	0.00119	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.22e-05	0.00074	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.06e-05	0.000643	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EP300—conduct disorder	1.04e-05	0.000631	CbGpPWpGaD
